FMP
Nyxoah S.A.
NYXH
NASDAQ
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
10.75 USD
0.35 (3.26%)
About
ceo
Mr. Olivier Taelman
sector
Healthcare
industry
Medical - Instruments & Supplies
website
https://www.nyxoah.com
exchange
NASDAQ
Description
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
CIK
0001857190
ISIN
BE0974358906
CUSIP
N/A
Address
Rue Edouard Belin 12
Phone
32 1 022 23 55
Country
BE
Employee
146
IPO Date
Apr 28, 2021
Summary
CIK
0001857190
Exchange
NASDAQ
Industry
Medical - Instrument...
Sector
Healthcare
CUSIP
-
ISIN
BE0974358906
Country
BE
Price
10.75
Beta
0.48
Volume Avg.
60.03k
Market Cap
308.12M
Shares
-
52-Week
4.0-20.0
DCF
-3.47
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-6.52
P/B
-
Website
https://www.nyxoah.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest NYXH News
It looks like there's no news available.
